Efgartigimod Sustains Sjögren's Disease Control Through 48 Weeks in RHO+ OLEByIsabelle Peene, MD, PhDJune 26th 2026
Autoantibody and IFN Burden Correlate With Nipocalimab Response in Sjögren's DiseaseByR. Hal Scofield, MDJune 10th 2026